- Home
- NCA vs BLDE Comparison
NCA vs BLDE Comparison
Compare NCA & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- BLDE
- Stock Information
- Founded
- NCA 1987
- BLDE 2014
- Country
- NCA United States
- BLDE United States
- Employees
- NCA N/A
- BLDE N/A
- Industry
- NCA Investment Managers
- BLDE Aerospace
- Sector
- NCA Finance
- BLDE Consumer Discretionary
- Exchange
- NCA Nasdaq
- BLDE Nasdaq
- Market Cap
- NCA N/A
- BLDE 215.1M
- IPO Year
- NCA N/A
- BLDE N/A
- Fundamental
- Price
- NCA $8.64
- BLDE $2.96
- Analyst Decision
- NCA
- BLDE Strong Buy
- Analyst Count
- NCA 0
- BLDE 2
- Target Price
- NCA N/A
- BLDE $6.25
- AVG Volume (30 Days)
- NCA 59.6K
- BLDE 541.6K
- Earning Date
- NCA 01-01-0001
- BLDE 05-12-2025
- Dividend Yield
- NCA 3.92%
- BLDE N/A
- EPS Growth
- NCA N/A
- BLDE N/A
- EPS
- NCA N/A
- BLDE N/A
- Revenue
- NCA N/A
- BLDE $248,693,000.00
- Revenue This Year
- NCA N/A
- BLDE $5.21
- Revenue Next Year
- NCA N/A
- BLDE $8.70
- P/E Ratio
- NCA N/A
- BLDE N/A
- Revenue Growth
- NCA N/A
- BLDE 10.44
- 52 Week Low
- NCA $7.77
- BLDE $2.35
- 52 Week High
- NCA $9.12
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- NCA 62.72
- BLDE 58.04
- Support Level
- NCA $8.42
- BLDE $2.73
- Resistance Level
- NCA $8.58
- BLDE $2.99
- Average True Range (ATR)
- NCA 0.09
- BLDE 0.12
- MACD
- NCA 0.03
- BLDE 0.04
- Stochastic Oscillator
- NCA 100.00
- BLDE 93.75
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.